Hélène Prunier Selected Research

Formoterol Fumarate (Oxis)

1/2018

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hélène Prunier Research Topics

Disease

2	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 01/2018
1	Pneumonia (Pneumonitis) 01/2018

Drug/Important Bio-Agent (IBA)

2	Bronchodilator Agents (Bronchodilators)IBA 01/2018 - 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Beclomethasone (Beclometasone)FDA Link 01/2018
1	indacaterolIBA 01/2018
1	Muscarinic AntagonistsIBA 01/2018
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2018
1	Formoterol Fumarate (Oxis)FDA Link 01/2018

Therapy/Procedure

1	Nebulizers and Vaporizers (Inhaler) 01/2018
1	Therapeutics 01/2018